Primary care plays a key role in the safe and effective provision of medicines to patients with cancer, including shared care prescribing and administration of treatments for breast and prostate cancer, medicines for long term prevention of relapse in breast cancer, and safe and effective provision of medicines at end of life.
MORPh Training study days provide the primary care pharmacist with an update on approaches to palliative care, including policies and practices, anticipatory care, deprescribing and symptom control at the end of life. A specific focus on prostate and breast cancers will consider the shared care provision of LHRH analogues, management of adverse effects and the importance of treatments to reduce the risk of relapse.
MORPh Training ‘Primary Care Role in the Managing of Patients in Primary Care’ will be held at the following locations:
Click the date to view the full agenda or visit www.morphconsultancy.co.uk/training
3rd May 2019, Leicester >> Book Your Free Place Here <<
11th June 2019, Manchester >> Book Your Free Place Here <<
16th July 2019, London *Save the Date*
19th November 2019, Birmingham *Save the Date*